37520 Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 

with either or both of these definitions, 

please explain why and provide 

alternative definitions. 

Authority: This proceeding is being 

conducted under authority of title VII of the 

Tariff Act of 1930; this notice is published 

pursuant to section 207.61 of the 

Commission’s rules. 

By order of the Commission. 

Issued: July 27, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–16435 Filed 7–31–18; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Bureau of Alcohol, Tobacco, Firearms 

and Explosives 

[OMB Number 1140–0101] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; National 

Firearms Act Division and Firearms 

and Explosives Services Division 

Customer Service Survey 

AGENCY: Bureau of Alcohol, Tobacco, 

Firearms and Explosives, Department of 

Justice. 

ACTION: 30-day notice. 

SUMMARY: The Department of Justice 

(DOJ), Bureau of Alcohol, Tobacco, 

Firearms and Explosives (ATF), will 

submit the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. A 

minor change is being made to the 

proposed collection OMB 1140–0101 

(Firearms and Explosives Services 

Division (FESD) Customer Service 

Survey), to include references to the 

recently established National Firearms 

Act Division (NFA Division); which was 

previously a branch in FESD. All survey 

questions directly relate to customer 

experience in FESD, NFA Division and 

their branches. The proposed collection 

is being published to obtain comments 

from the public and affected agencies. 

The proposed information collection 

was previously published in the Federal 

Register, on May 30, 2018, allowing for 

a 60-day comment period. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until August 31, 2018. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments, 

particularly with respect to the 

estimated public burden or associated 

response time, have suggestions, need a 

copy of the proposed information 

collection instrument with instructions, 

or desire any other additional 

information, please contact Erica Payne, 

National Firearms Act Division, either 

by mail at 244 Needy Road, 

Martinsburg, WV 25405, by email at 

Erica.payne@atf.gov or by telephone at 

304–616–4582. Written comments and/ 

or suggestions can also be directed to 

the Office of Management and Budget, 

Office of Information and Regulatory 

Affairs, Attention Department of Justice 

Desk Officer, Washington, DC 20503 or 

sent to OIRA_submissions@

omb.eop.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Extension, with change, of a currently 

approved collection. 

(2) The Title of the Form/Collection: 

National Firearms Act Division and 

Firearms and Explosives Services 

Division Customer Service Survey. 

(3) The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

Form number: None. 

Component: Bureau of Alcohol, 

Tobacco, Firearms and Explosives, U.S. 

Department of Justice. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Primary: Business or other for-profit. 

Other: Individuals or Households, 

Federal Government, and State, Local, 

or Tribal Government. 

Abstract: The purpose of this survey 

is to gather information about customer 

service provided to the firearms and 

explosives industry and government 

agencies, in order to improve service 

delivery and customer satisfaction. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: An estimated 18,200 

respondents will utilize this survey, and 

it will take each respondent 

approximately 5 minutes to complete 

their responses. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: The estimated annual public 

burden associated with this collection is 

1,517 hours which is equal to: 18,200 

(total # of responses) * .0833333 (5 

minutes). 

If additional information is required 

contact: Melody Braswell, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, 3E.405A, 

Washington, DC 20530. 

Date: July 27, 2018. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2018–16487 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–14–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Chemtos, 

LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before October 1, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 37521 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

delegated to the Assistant Administrator 

of the DEA Diversion Control Division 

(‘‘Assistant Administrator’’) pursuant to 

section 7 of 28 CFR part 0, appendix to 

subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on June 

11, 2018, Chemtos, LLC, 14101 West 

Highway 290, Building 2000B, Austin, 

Texas 78737 applied to be registered as 

a bulk manufacturer of the following 

basic classes of controlled substances: 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3–FMC) ..................................................................................................................... 1233 I 

Cathinone ................................................................................................................................................................. 1235 I 

Methcathinone ......................................................................................................................................................... 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ..................................................................................................................... 1238 I 

Pentedrone (a-methylaminovalerophenone) ........................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................ 1248 I 

4-Methyl-N-ethylcathinone (4–MEC) ....................................................................................................................... 1249 I 

Naphyrone ............................................................................................................................................................... 1258 I 

N-Ethylamphetamine ............................................................................................................................................... 1475 I 

N,N-Dimethylamphetamine ...................................................................................................................................... 1480 I 

Fenethylline .............................................................................................................................................................. 1503 I 

Aminorex .................................................................................................................................................................. 1585 I 

4-Methylaminorex (cis isomer) ................................................................................................................................ 1590 I 

Gamma Hydroxybutyric Acid ................................................................................................................................... 2010 I 

Methaqualone .......................................................................................................................................................... 2565 I 

Mecloqualone ........................................................................................................................................................... 2572 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................... 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................ 7008 I 

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..... 7010 I 

5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........ 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7012 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................. 7019 I 

MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .............. 7020 I 

AB–PINACA (N-(1-amino-3-methyl- ........................................................................................................................

1-oxobutan-2-yl)-1-pentyl-1H-indazole- ...................................................................................................................

3-carboxamide) ........................................................................................................................................................ 7023 I 

THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................

yl](naphthalen-1-yl)methanone ................................................................................................................................ 7024 I 

AB–CHMINACA (N-(1-amino-3-methyl-1- ...............................................................................................................

oxobutan-2-yl)-1-(cyclohexylmethyl)- .......................................................................................................................

1H-indazole-3-carboxamide ..................................................................................................................................... 7031 I 

MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) 7032 I 

5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ...................................... 7033 I 

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3- 

dimethylbutanoate) ............................................................................................................................................... 7034 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................... 7035 I 

MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- 

dimethylbutanoate) ............................................................................................................................................... 7042 I 

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ....................................................... 7048 I 

5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................... 7049 I 

JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................... 7081 I 

SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................ 7104 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... 7118 I 

JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................. 7122 I 

UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ......................................................... 7144 I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................... 7173 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................. 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................... 7201 I 

JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................. 7203 I 

PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................... 7222 I 

5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................... 7225 I 

Alpha-ethyltryptamine .............................................................................................................................................. 7249 I 

Ibogaine ................................................................................................................................................................... 7260 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................... 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................... 7298 I 

Lysergic acid diethylamide ...................................................................................................................................... 7315 I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ...................................................................................... 7348 I 

Marihuana Extract .................................................................................................................................................... 7350 I 

Marihuana ................................................................................................................................................................ 7360 I 

Parahexyl ................................................................................................................................................................. 7374 I 

Mescaline ................................................................................................................................................................. 7381 I 

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) .................................................................................. 7385 I 

3,4,5-Trimethoxyamphetamine ................................................................................................................................ 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................... 7391 I 


sradovich on DSK3GMQ082PROD with NOTICES
37522 Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 

Controlled substance Drug code Schedule 

4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................... 7395 I 

2,5-Dimethoxyamphetamine .................................................................................................................................... 7396 I 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................. 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................ 7399 I 

3,4-Methylenedioxyamphetamine ............................................................................................................................ 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine .................................................................................................................... 7405 I 

4-Methoxyamphetamine .......................................................................................................................................... 7411 I 

5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................ 7431 I 

Alpha-methyltryptamine ........................................................................................................................................... 7432 I 

Bufotenine ................................................................................................................................................................ 7433 I 

Diethyltryptamine ..................................................................................................................................................... 7434 I 

Dimethyltryptamine .................................................................................................................................................. 7435 I 

Psilocybin ................................................................................................................................................................. 7437 I 

Psilocyn .................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ...................................................................................................................... 7439 I 

N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................ 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................ 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................... 7470 I 

1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ...................................................................................................................... 7473 I 

N-Ethyl-3-piperidyl benzilate .................................................................................................................................... 7482 I 

N-Methyl-3-piperidyl benzilate ................................................................................................................................. 7484 I 

N-Benzylpiperazine .................................................................................................................................................. 7493 I 

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .............................................................................................. 7498 I 

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .......................................................................................... 7508 I 

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ............................................................................................ 7509 I 

2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ......................................................................................................... 7517 I 

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ................................................................................................ 7518 I 

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .......................................................................................... 7519 I 

2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ............................................................................................ 7521 I 

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ..................................................................................... 7524 I 

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ........................................................................... 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................... 7535 I 

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ............................................ 7536 I 

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ............................................ 7537 I 

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ................................................. 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................. 7540 I 

Butylone ................................................................................................................................................................... 7541 I 

Pentylone ................................................................................................................................................................. 7542 I 

alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................ 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................. 7546 I 

AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ........................................................................................... 7694 I 

Acetyldihydrocodeine ............................................................................................................................................... 9051 I 

Benzylmorphine ....................................................................................................................................................... 9052 I 

Codeine-N-oxide ...................................................................................................................................................... 9053 I 

Cyprenorphine ......................................................................................................................................................... 9054 I 

Desomorphine .......................................................................................................................................................... 9055 I 

Etorphine (except HCl) ............................................................................................................................................ 9056 I 

Codeine methylbromide ........................................................................................................................................... 9070 I 

Dihydromorphine ...................................................................................................................................................... 9145 I 

Difenoxin .................................................................................................................................................................. 9168 I 

Heroin ...................................................................................................................................................................... 9200 I 

Hydromorphinol ........................................................................................................................................................ 9301 I 

Methyldesorphine ..................................................................................................................................................... 9302 I 

Methyldihydromorphine ............................................................................................................................................ 9304 I 

Morphine methylbromide ......................................................................................................................................... 9305 I 

Morphine methylsulfonate ........................................................................................................................................ 9306 I 

Morphine-N-oxide .................................................................................................................................................... 9307 I 

Myrophine ................................................................................................................................................................ 9308 I 

Nicocodeine ............................................................................................................................................................. 9309 I 

Nicomorphine ........................................................................................................................................................... 9312 I 

Normorphine ............................................................................................................................................................ 9313 I 

Pholcodine ............................................................................................................................................................... 9314 I 

Thebacon ................................................................................................................................................................. 9315 I 

Acetorphine .............................................................................................................................................................. 9319 I 

Drotebanol ............................................................................................................................................................... 9335 I 

U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...................................................... 9547 I 

AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .......................................................... 9551 I 

Acetylmethadol ........................................................................................................................................................ 9601 I 

Allylprodine .............................................................................................................................................................. 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol .............................................................................................. 9603 I 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 37523 

Controlled substance Drug code Schedule 

Alphameprodine ....................................................................................................................................................... 9604 I 

Alphamethadol ......................................................................................................................................................... 9605 I 

Benzethidine ............................................................................................................................................................ 9606 I 

Betacetylmethadol ................................................................................................................................................... 9607 I 

Betameprodine ......................................................................................................................................................... 9608 I 

Betamethadol ........................................................................................................................................................... 9609 I 

Betaprodine .............................................................................................................................................................. 9611 I 

Clonitazene .............................................................................................................................................................. 9612 I 

Dextromoramide ...................................................................................................................................................... 9613 I 

Diampromide ............................................................................................................................................................ 9615 I 

Diethylthiambutene .................................................................................................................................................. 9616 I 

Dimenoxadol ............................................................................................................................................................ 9617 I 

Dimepheptanol ......................................................................................................................................................... 9618 I 

Dimethylthiambutene ............................................................................................................................................... 9619 I 

Dioxaphetyl butyrate ................................................................................................................................................ 9621 I 

Dipipanone ............................................................................................................................................................... 9622 I 

Ethylmethylthiambutene ........................................................................................................................................... 9623 I 

Etonitazene .............................................................................................................................................................. 9624 I 

Etoxeridine ............................................................................................................................................................... 9625 I 

Furethidine ............................................................................................................................................................... 9626 I 

Hydroxypethidine ..................................................................................................................................................... 9627 I 

Ketobemidone .......................................................................................................................................................... 9628 I 

Levomoramide ......................................................................................................................................................... 9629 I 

Levophenacylmorphan ............................................................................................................................................. 9631 I 

Morpheridine ............................................................................................................................................................ 9632 I 

Noracymethadol ....................................................................................................................................................... 9633 I 

Norlevorphanol ......................................................................................................................................................... 9634 I 

Normethadone ......................................................................................................................................................... 9635 I 

Norpipanone ............................................................................................................................................................ 9636 I 

Phenadoxone ........................................................................................................................................................... 9637 I 

Phenampromide ....................................................................................................................................................... 9638 I 

Phenoperidine .......................................................................................................................................................... 9641 I 

Piritramide ................................................................................................................................................................ 9642 I 

Proheptazine ............................................................................................................................................................ 9643 I 

Properidine ............................................................................................................................................................... 9644 I 

Racemoramide ......................................................................................................................................................... 9645 I 

Trimeperidine ........................................................................................................................................................... 9646 I 

Phenomorphan ........................................................................................................................................................ 9647 I 

Propiram .................................................................................................................................................................. 9649 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................... 9661 I 

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ...................................................................................................... 9663 I 

Tilidine ...................................................................................................................................................................... 9750 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ......................................................................... 9811 I 

Para-Fluorofentanyl ................................................................................................................................................. 9812 I 

3-Methylfentanyl ....................................................................................................................................................... 9813 I 

Alpha-methylfentanyl ............................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ..................................................................................................................................... 9815 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................... 9821 I 

Butyryl Fentanyl ....................................................................................................................................................... 9822 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ................................. 9824 I 

Beta-hydroxyfentanyl ............................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl .......................................................................................................................................... 9832 I 

3-Methylthiofentanyl ................................................................................................................................................. 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ..................................................... 9834 I 

Thiofentanyl ............................................................................................................................................................. 9835 I 

Beta-hydroxythiofentanyl ......................................................................................................................................... 9836 I 

Amphetamine ........................................................................................................................................................... 1100 II 

Methamphetamine ................................................................................................................................................... 1105 II 

Lisdexamfetamine .................................................................................................................................................... 1205 II 

Phenmetrazine ......................................................................................................................................................... 1631 II 

Methylphenidate ....................................................................................................................................................... 1724 II 

Amobarbital .............................................................................................................................................................. 2125 II 

Pentobarbital ............................................................................................................................................................ 2270 II 

Secobarbital ............................................................................................................................................................. 2315 II 

Glutethimide ............................................................................................................................................................. 2550 II 

Nabilone ................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ........................................................................................................................................ 7460 II 

Phencyclidine ........................................................................................................................................................... 7471 II 

4-Anilino-N-phenethyl-4-piperidine (ANPP) ............................................................................................................. 8333 II 

Phenylacetone ......................................................................................................................................................... 8501 II 

1-Piperidinocyclohexanecarbonitrile ........................................................................................................................ 8603 II 

Alphaprodine ............................................................................................................................................................ 9010 II 

Anileridine ................................................................................................................................................................ 9020 II 


sradovich on DSK3GMQ082PROD with NOTICES
37524 Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 

Controlled substance Drug code Schedule 

Cocaine .................................................................................................................................................................... 9041 II 

Codeine .................................................................................................................................................................... 9050 II 

Etorphine HCl .......................................................................................................................................................... 9059 II 

Dihydrocodeine ........................................................................................................................................................ 9120 II 

Oxycodone ............................................................................................................................................................... 9143 II 

Hydromorphone ....................................................................................................................................................... 9150 II 

Diphenoxylate .......................................................................................................................................................... 9170 II 

Ecgonine .................................................................................................................................................................. 9180 II 

Ethylmorphine .......................................................................................................................................................... 9190 II 

Hydrocodone ............................................................................................................................................................ 9193 II 

Levomethorphan ...................................................................................................................................................... 9210 II 

Levorphanol ............................................................................................................................................................. 9220 II 

Isomethadone .......................................................................................................................................................... 9226 II 

Meperidine ............................................................................................................................................................... 9230 II 

Meperidine intermediate-A ....................................................................................................................................... 9232 II 

Meperidine intermediate-B ....................................................................................................................................... 9233 II 

Meperidine intermediate-C ...................................................................................................................................... 9234 II 

Methadone ............................................................................................................................................................... 9250 II 

Methadone intermediate .......................................................................................................................................... 9254 II 

Metopon ................................................................................................................................................................... 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... 9273 II 

Morphine .................................................................................................................................................................. 9300 II 

Thebaine .................................................................................................................................................................. 9333 II 

Dihydroetorphine ...................................................................................................................................................... 9334 II 

Levo-alphacetylmethadol ......................................................................................................................................... 9648 II 

Oxymorphone .......................................................................................................................................................... 9652 II 

Noroxymorphone ..................................................................................................................................................... 9668 II 

Phenazocine ............................................................................................................................................................ 9715 II 

Thiafentanil .............................................................................................................................................................. 9729 II 

Piminodine ............................................................................................................................................................... 9730 II 

Racemethorphan ..................................................................................................................................................... 9732 II 

Racemorphan .......................................................................................................................................................... 9733 II 

Alfentanil .................................................................................................................................................................. 9737 II 

Remifentanil ............................................................................................................................................................. 9739 II 

Sufentanil ................................................................................................................................................................. 9740 II 

Carfentanil ................................................................................................................................................................ 9743 II 

Tapentadol ............................................................................................................................................................... 9780 II 

Bezitramide .............................................................................................................................................................. 9800 II 

Fentanyl ................................................................................................................................................................... 9801 II 

Moramide-intermediate ............................................................................................................................................ 9802 II 

The company plans to manufacture 

small quantities of the listed controlled 

substances in bulk for distribution to its 

customers. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16468 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Cody Laboratories Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before August 31, 2018. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before August 31, 

2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and request for hearing on 

applications to import narcotic raw 

material are not appropriate. 72 FR 3417 

(January 25, 2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 

20, 2018, Cody Laboratories, Inc., Steve 

Hartman, 601 Yellowstone Avenue, 

Cody, Wyoming 82414–9221 applied to 

be registered as an importer of the 

following basic classes of controlled 

substances: 


sradovich on DSK3GMQ082PROD with NOTICES